|
EP2598131A1
|
|
Compounds for the treatment/prevention of ocular inflammatory diseases
|
|
FR2963238A1
|
|
15-desoxyspergualine derivatives for the treatment and / or prevention of ocular inflammatory diseases
|
|
FR2955110A1
|
|
Novel benzoic pyrrolopyridine derivatives
|
|
FR2950058A1
|
|
USE OF BENZOIC INDOLE DERIVATIVES AS NURR-1 ACTIVATORS FOR THE TREATMENT OF PARKINSON'S DISEASE
|
|
FR2955108A1
|
|
USE OF PYRROLOPYRIDINE DERIVATIVES AS NURR-1 ACTIVATORS FOR THE TREATMENT OF PARKINSON'S DISEASE
|
|
FR2933609A1
|
|
Use of indole derivatives as nurr-1 activators for the treatment of parkinson's disease.
|
|
MY143462A
|
|
Novel indoline compounds
|
|
WO2008037923A1
|
|
New derivatives of 5-thioxilopyranose
|
|
CN101535329A
|
|
Derivatives of 5-thioxylopyranose and use of same for treatment
|
|
CA2658256A1
|
|
New 5-thioxylopyranose derivatives
|
|
ZA200801885B
|
|
Pyrrolopyridine derivatives and use of same as PPAR receptor modulators
|
|
RS51332B
|
|
Indole derivatives as ppar activators
|
|
KR20080021609A
|
|
Novel indoline compound
|
|
MX2007014088A
|
|
Novel use of liver x receptor agonists.
|
|
BRPI0609211A2
|
|
5-thioxylose-derived compounds and their therapeutic uses
|
|
EP1785133A1
|
|
Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
|
|
CN102321020A
|
|
The lxr receptor regulator
|
|
UA83821C2
|
|
Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
|
|
CA2500977A1
|
|
2-thiohydantoine derivative compounds and use thereof in therapeutics
|
|
FR2860234A1
|
|
New thioxylose derivatives 666
|
